General Maritime Corp. | |||
New York | |||
Went public 06/12/01 at $12 per share | |||
Filing Range: | 8.0 million shares at $17 to $19 | ||
Offering Size: | $126 million | ||
Post Offering Valuation: | $617.0 million | ||
Shares Outstanding: | 28.0 million shares | ||
Underwriters: | Lehman Brothers/Jefferies & Co./ABN AMRO Rothschild | ||
Company Counsel: | Kramer, Levin, Naftalis & Frankel | ||
Manager Counsel: | Stroock, Stroock & Lavan | ||
Auditor: | Deloitte & Touche LLP | ||
The Company | |||
Provides international seaborne crude oil transportation services. | |||
Venture Backers | |||
Moore Capital Management Inc. | |||
Oaktree Capital Management LLC | |||
Wexford Management LLC | |||
Financing Rounds | |||
Round # | Round Date | Number of Stage Investors | Round Amt. ($ thousands) |
1 | 1/1/01 | 3 Expansion | N/A |
Financials | |||
(Data in $ millions except EPS) | Y/E (12/31/00) | ||
Total Revenues: | $132.00 | ||
Net Income: | 30.3 | ||
EPS: | 1.6 |
Monolithic System Technology Inc. | |||
Sunnyvale, Calif. | |||
Went public 06/28/01 at $28 per share | |||
Filing Range: | 5.0 million shares at $9 to $11 | ||
Offering Size: | $50.0 million | ||
Post Offering Valuation: | $296.5 million | ||
Shares Outstanding: | 31.0 million shares | ||
Underwriters: | A.G. Edwards & Sons Inc./Needham & Co. | ||
Company Counsel: | McCutchen, Doyle, Brown & Enersen LLP | ||
Manager Counsel: | Morrison & Foerster | ||
Auditor: | Pricewaterhouse Coopers LLP | ||
The Company | |||
Manufactures and markets performance memory chip technologies such as multibanking, multibank caching, I/O switching and data streaming. The company supplies memory products to major video/graphics, personal computer and laptop businesses. | |||
Venture Backers | |||
West Coast Venture Capital | |||
DynaFund Ventures LLC | |||
Financing Rounds | |||
Round # | Round Date | Number of Stage Investors | Round Amt. ($ thousands) |
1 | 11/30/97 | 2 Early Stage | 1,595 |
2 | 4/30/98 | 1 Expansion | 8,061 |
3 | 5/13/00 | 1 Later Stage | 5,200 |
Financials | |||
(Data in $ millions except EPS) | Y/E (12/31/00) | ||
Total Revenues: | $14.30 | ||
Net Income: | 1.3 | ||
EPS: | 0.13 |
MultiLink Technology Corp. | |||
Somerset, N.J. | |||
Went public 06/21/01 at $9 per shares | |||
Filing Range: | 8.0 million shares at $8 to $10 | ||
Offering Size: | $72 million | ||
Post Offering Valuation: | $586.5 million | ||
Shares Outstanding: | 65.1 million shares | ||
Underwriters: | Credit Suisse First Boston/Salomon Smith Barney/Thomas Weisel Partners LLC | ||
Company Counsel: | Allen, Matkins, Leck & Mallory LLP | ||
Manager Counsel: | Cravath, Swaine & Moore | ||
Auditor: | Deloitte & Touche LLP | ||
The Company | |||
Designs and manufactures integrated circuits, modules and boards. The company focuses on high bit-rate connectivity solutions serving the needs of a majority of the Tier 1 telecommunications and data communication companies. | |||
Venture Backers | |||
Brentwood Venture Capital | |||
Meritech Capital Partners | |||
IBM Corp. | |||
Redpoint Ventures | |||
TRW Inc. | |||
Financing Rounds | |||
Round # | Round Date | Number of Stage Investors | Round Amt. ($ thousands) |
1 | 6/1/99 | 3 Early Stage | 15,405 |
2 | 5/31/00 | 5 Expansion | 40,000 |
Financials | |||
(Data in $ millions except EPS) | Y/E (12/31/00) | ||
Total Revenues: | $72.70 | ||
Net Income: | -3.7 | ||
EPS: | -0.34 |
The Princeton Review | |||
New York | |||
Went public 06/19/01 at $11 per share | |||
Filing Range: | 5.4 million shares at $11 to $13 | ||
Offering Size: | $59.4 million | ||
Post Offering Valuation: | $286.9 million | ||
Shares Outstanding: | 25.79 million shares | ||
Underwriters: | U.S. Bancorp Piper Jaffray/Legg Mason Wood Walker/J.P. Morgan Securities | ||
Company Counsel: | Patterson, Belknap, Webb & Tyler | ||
Manager Counsel: | Dewey Ballantine LLP | ||
Auditor: | Ernst & Young LLP | ||
The Company | |||
Provides test preparation, college admissions and online education services. The company offers admissions counselors and tutors, as well as books and software designed to prepare students for college and graduate school entrance examinations. | |||
Venture Backers | |||
Societe Generale | |||
Olympus Advisory Partners Inc. | |||
Financing Rounds | |||
Round # | Round Date | Number of Stage Investors | Round Amt. ($ thousands) |
1 | 5/23/00 | 2 Early Stage | 26,907 |
Financials | |||
(Data in $ millions except EPS) | Y/E (12/31/00) | ||
Total Revenues: | $43.90 | ||
Net Income: | -8.2 | ||
EPS: | -1.07 |
Torch Offshore Inc. | |||
Gretna, La. | |||
Went public 06/07/01 at $16 per share | |||
Filing Range: | 5.0 million shares at $14 to $16 | ||
Offering Size: | $80.0 million | ||
Post Offering Valuation: | $213.3 million | ||
Shares Outstanding: | 13.3 million shares | ||
Underwriters: | UBS Warburg/CIBC World Markets/Howard Weil Labouisse Freid | ||
Company Counsel: | Baker Botts LLP | ||
Manager Counsel: | Vinson & Elkins LLP | ||
Auditor: | Arthur Andersen LLP | ||
The Company | |||
Provides pipe laying and subsea construction services to the oil and gas industry. | |||
Venture Backers | |||
Riverside Management Group | |||
Financing Rounds | |||
Round # | Round Date | Number of Stage Investors | Round Amt. ($ thousands) |
1 | 1/26/01 | 1 Expansion | N/A |
Financials | |||
(Data in $ millions except EPS) | Y/E (12/31/00) | ||
Total Revenues: | $46.20 | ||
Net Income: | -1.6 | ||
EPS: | -0.82 |
Unilab Corp. | |||
Tarzana, Calif. | |||
Went public 06/06/01 at $16 per share | |||
Filing Range: | 6.7 million shares at $14 to $16 | ||
Offering Size: | $100.5 million | ||
Post Offering Valuation: | $464.1 million | ||
Shares Outstanding: | 32.2 million shares | ||
Underwriters: | Salomon Smith Barney/Credit Suisse First Boston/U.S. Bancorp Piper Jaffray | ||
Company Counsel: | Skadden, Arps, Slate, Meagher & Flom | ||
Manager Counsel: | Debevoise & Plimpton | ||
Auditor: | Deloitte & Touche LLP | ||
The Company | |||
Provides clinical laboratory services which fall into two general classes of tests: routine and esoteric. The company’s routine or commonly ordered tests include blood cholesterol tests used in the detection of early heart disease; glucose tests to identify diabetes; blood cell measurements; PAP smears used to screen for cervical cancer; and AIDS screening. Esoteric tests, which are ordered infrequently and usually require more specialized equipment, include hepatitis and cancer markers. | |||
Venture Backers | |||
Kelso & Co. | |||
Financing Rounds | |||
Round # | Round Date | Number of Stage Investors | Round Amt. ($ thousands) |
1 | 9/1/98 | 1 Expansion | 27,495 |
2 | 11/1/99 | 1 Expansion | 139,600 |
3 | 7/1/00 | 1 Expansion | 21,094 |
Financials | |||
(Data in $ millions except EPS) | Y/E (12/31/00) | ||
Total Revenues: | $337.50 | ||
Net Income: | 41.6 | ||
EPS: | 1.63 |
United Surgical Partners International | |||
Dallas | |||
Went public 06/08/01 at $14 per share | |||
Filing Range: | 9.0 million shares at $13 to $15 | ||
Offering Size: | $126 million | ||
Post Offering Valuation: | $321.5 million | ||
Shares Outstanding: | 23.0 million | ||
Underwriters: | Credit Suisse First Boston/Lehman Brothers/SG Cowen Securities | ||
Company Counsel: | Vinson & Elkins LLP | ||
Manager Counsel: | Akin, Gump, Strauss, Havrot & Feld, LLC | ||
Auditor: | KPMG LLP | ||
The Company | |||
Develops and acquires surgical facilities in the U.S. and Europe. The company acquires and manages ambulatory surgery centers in the U.S. and private surgical hospitals in Europe. It works in partnership with local physicians and, wherever possible, with a local hospital or health system. | |||
Venture Backers | |||
Welsh, Carson, Anderson & Stowe | |||
Financing Rounds | |||
Round # | Round Date | Number of Stage Investors | Round Amt. ($ thousands) |
1 | 3/2/98 | 1 Buyout/Acq. | 12,965 |
2 | 7/1/98 | 1 Buyout/Acq. | 10,556 |
3 | 4/1/99 | 2 Buyout/Acq. | 54,750 |
Financials | |||
(Data in $ millions except EPS) | Y/E (12/31/00) | ||
Total Revenues: | $135.00 | ||
Net Income: | -8.3 | ||
EPS: | -1.82 |